RCKT: Rocket Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 592.86
Enterprise Value ($M) 429.23
Book Value ($M) 463.23
Book Value / Share 4.34
Price / Book 1.28
NCAV ($M) 313.72
NCAV / Share 2.94
Price / NCAV 1.89

Profitability (mra)
Return on Invested Capital (ROIC) -0.53
Return on Assets (ROA) -0.52
Return on Equity (ROE) -0.53

Liquidity (mrq)
Quick Ratio 9.30
Current Ratio 9.30

Balance Sheet (mrq) ($M)
Current Assets 378.18
Assets 527.70
Liabilities 64.47
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -273.20
Net Income -258.75
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -209.72
Cash from Investing 131.71
Cash from Financing 185.74

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-10 13G/A Wellington Management Group Llp 13.40 24.49
12-16 13D/A Rtw Investments, Lp 17.60

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-04 456,608 4,539,026 10.06
2025-04-03 486,074 4,091,041 11.88
2025-04-02 560,499 4,113,918 13.62
2025-04-01 821,179 7,115,000 11.54

(click for more detail)

Similar Companies
PTGX – Protagonist Therapeutics, Inc. RANI – Rani Therapeutics Holdings, Inc.
RAPT – RAPT Therapeutics, Inc. RLAY – Relay Therapeutics, Inc.
RNA – Avidity Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Rocket Pharmaceuticals